H
Hauke Lang
Researcher at University of Mainz
Publications - 605
Citations - 15436
Hauke Lang is an academic researcher from University of Mainz. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 54, co-authored 551 publications receiving 12894 citations. Previous affiliations of Hauke Lang include Otto-von-Guericke University Magdeburg & Hochschule Hannover.
Papers
More filters
Journal ArticleDOI
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.
Andreas A. Schnitzbauer,Sven A. Lang,H. Goessmann,Silvio Nadalin,Janine Baumgart,Stefan Farkas,Stefan Fichtner-Feigl,Thomas Lorf,Armin Goralcyk,Rüdiger Hörbelt,Alexander Kroemer,Martin Loss,Petra Rümmele,Marcus N. Scherer,Winfried Padberg,Alfred Königsrainer,Hauke Lang,Aiman Obed,Hans J. Schlitt +18 more
TL;DR: Two-step hepatic resection performing surgical exploration, PVL, and ISS results in a marked and rapid hypertrophy of functional liver tissue and enables curative resection of marginally resectable liver tumors or metastases in patients that might otherwise be regarded as palliative.
Journal ArticleDOI
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
Gunnar Folprecht,Thomas Gruenberger,Wolf O. Bechstein,Hans-Rudolf Raab,Florian Lordick,Jörg T. Hartmann,Hauke Lang,Andrea Frilling,Jan Stoehlmacher,Jürgen Weitz,Ralf Konopke,Christian Stroszczynski,Torsten Liersch,Detlev Ockert,Thomas Herrmann,Eray Goekkurt,Fabio Parisi,Claus-Henning Köhne +17 more
TL;DR: In this paper, the effectiveness of cetuximab combined with chemotherapy in this setting was assessed, and the primary endpoint was tumour response assessed by Response Evaluation Criteria In Solid Tumours (RECIST), analysed by modified intention to treat.
Journal ArticleDOI
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation.
Mohammad Abu Hilal,Luca Aldrighetti,Ibrahim Dagher,Bjørn Edwin,Roberto Troisi,Ruslan Alikhanov,Somaiah Aroori,Giulio Belli,Marc G. Besselink,Javier Briceño,Brice Gayet,Mathieu D'Hondt,Mickael Lesurtel,Krishna Menon,Peter Lodge,Fernando Rotellar,Julio Santoyo,Olivier Scatton,Olivier Soubrane,Robert P. Sutcliffe,Ronald M. van Dam,Steve White,Mark Halls,Federica Cipriani,Marcel J. van der Poel,Ruben Ciria,Leonid Barkhatov,Yrene Gomez-Luque,Sira Ocana-Garcia,Andrew Cook,Joseph E. Buell,Pierre-Alain Clavien,Christos Dervenis,Giuseppe Fusai,David A. Geller,Hauke Lang,John N. Primrose,Mark A. Taylor,Thomas M. van Gulik,Go Wakabayashi,Horacio J. Asbun,Daniel Cherqui +41 more
TL;DR: The Southampton Guidelines have amalgamated the available evidence and a wealth of experts’ knowledge taking in consideration the relevant stakeholders’ opinions and complying with the international methodology standards.
Journal ArticleDOI
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment.
Maartje A. J. van den Broek,Steven W.M. Olde Damink,Cornelis H. C. Dejong,Hauke Lang,Hauke Lang,Massimo Malagó,Massimo Malagó,Rajiv Jalan,Fuat H. Saner +8 more
TL;DR: A systematic computerized search was performed using key words related to ‘partial hepatic resection’ and ‘liver failure’ to review most relevant literature about PLF published in the last 20 years.
Journal ArticleDOI
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
Klaus Juergen Schmitz,Jeremias Wohlschlaeger,Hauke Lang,Georgios C. Sotiropoulos,Massimo Malagó,Karen Steveling,Henning Reis,Vito R. Cicinnati,Kurt Werner Schmid,Hideo Baba +9 more
TL;DR: Investigation of the prognostic relevance of AKT and ERK1/2 in HCC cancer indicates aggressive tumour behaviour and constitutes an independent prognostic factor, and data confirm that HCV infection activates the ERK pathway and thereby might contribute to HCC carcinogenesis.